Diagnos Inc V.ADK

Alternate Symbol(s): DGNOF

Technology Information Technology Services

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.

TSXV:ADK - Post by User

Diagnos Inc

Bullboard Posts

Comment by u2bobon Aug 16, 2017 11:03am

117 Views

Post# 26587366

RE:Two things we need.

Bobbystallone wrote: In my opinion from the AGM meeting, the two things needed for this stock to move up quickly is the completion of the DTC Certificat on the OTC so that way American investors can purchase the stock, and progress on their cardio retinopathy.

Again that's my take but I'm also a long term investor, but everyone should do their own DD,

best regards Bobby,

I would think once approval for DTC happens... there would be a NR...followed up quickly with OTCQB Update for DGNOF...

DGNOF Security Details

Share Structure

Market Value¹	$14,972,556	a/o Aug 15, 2017
Authorized Shares	Unlimited	a/o Jun 01, 2017
Outstanding Shares	149,277,729	a/o Mar 31, 2017
-Restricted	Not Available
-Unrestricted	Not Available
Held at DTC	Not Available
Float	Not Available
Par Value	No Par Value